Works about PROGRAMMED cell death 1 receptors

Results: 5000

The Clinical and Economic Value of Follow-on Biologics: Biosimilars, Biobetters, and Bioparallels.

Published in:

British Journal of Hospital Medicine (17508460), 2025, v. 86, n. 6, p. 1, doi. 10.12968/hmed.2024.1036

By:

Abraham, Ivo;
Beddor, Ansam Nail;
MacDonald, Karen Michelle

Publication type:

Article

Author Correction: ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy.

Published in:

2025

By:

Xiao, Xiangling;
Shi, Jie;
He, Chuan;
Bu, Xia;
Sun, Yishuang;
Gao, Minling;
Xiang, Bolin;
Xiong, Wenjun;
Dai, Panpan;
Mao, Qi;
Xing, Xixin;
Yao, Yingmeng;
Yu, Haisheng;
Xu, Gaoshan;
Li, Siqi;
Ren, Yan;
Chen, Baoxiang;
Jiang, Congqing;
Meng, Geng;
Lee, Yu-Ru

Publication type:

Correction Notice

Integrated peripheral blood multi-omics profiling identifies immune signatures predictive of neoadjuvant PD-1 blockade efficacy in head and neck squamous cell carcinoma.

Published in:

Journal of Translational Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12967-025-06770-2

By:

Zhang, Hao;
Wu, Wenjie;
Wang, Meng;
Zhang, Jie;
Guo, Chuanbin;
Han, Guojun;
Wang, Lin

Publication type:

Article

The antitumor immune response generated by fractionated radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade.

Published in:

OncoImmunology, 2015, v. 4, n. 7, p. N.PAG, doi. 10.1080/2162402X.2015.1016709

By:

Dovedi, S J;
Illidge, T M

Publication type:

Article

PD-L1 expression and tumor-infiltrating lymphocytes.

Published in:

OncoImmunology, 2014, v. 3, n. 6, p. N.PAG, doi. 10.4161/onci.29288

By:

Schalper, Kurt A

Publication type:

Article

Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytes.

Published in:

OncoImmunology, 2014, v. 3, n. 6, p. N.PAG, doi. 10.4161/onci.29244

By:

Robert, Lidia;
Harview, Christina;
Emerson, Ryan;
Wang, Xiaoyan;
Mok, Stephen;
Homet, Blanca;
Comin-Anduix, Begonya;
Koya, Richard C;
Robins, Harlan;
Tumeh, Paul C;
Ribas, Antoni

Publication type:

Article

Understanding the influence of the tumor microenvironment on macrophage responses to CD40 agonists.

Published in:

OncoImmunology, 2014, v. 3, n. 2, p. N.PAG, doi. 10.4161/onci.27615

By:

Luheshi, Nadia;
Davies, Gareth;
Legg, James

Publication type:

Article

Immune checkpoint blockade in malignant mesothelioma.

Published in:

OncoImmunology, 2014, v. 3, n. 2, p. N.PAG, doi. 10.4161/onci.27482

By:

Calabrò, Luana;
Maio, Michele

Publication type:

Article

Out of the bitter came forth sweet.

Published in:

OncoImmunology, 2014, v. 3, n. 2, p. N.PAG, doi. 10.4161/onci.27399

By:

Ankri, Chen;
Cohen, Cyrille J

Publication type:

Article

The immune landscape of human tumors.

Published in:

OncoImmunology, 2014, v. 3, n. 2, p. N.PAG, doi. 10.4161/onci.27456

By:

Bindea, Gabriela;
Mlecnik, Bernhard;
Angell, Helen K;
Galon, Jérôme

Publication type:

Article

The Treatment of Pembrolizumab-Induced Pruritus with Topical Roflumilast Cream 0.3% Once Daily.

Published in:

Journal of Clinical & Aesthetic Dermatology, 2025, v. 18, n. 5, p. 36

By:

LOMAX, LAURA

Publication type:

Article

Treatment strategies for rapid recurrence and progression after surgery for stage I pulmonary pleomorphic carcinoma: a case report and literature review.

Published in:

2025

By:

Zhang, Jing;
Xiong, Wenji;
Wang, Hong;
Sun, Lemeng;
Chen, Chen;
Sun, Xueru;
Man, Xiuyue;
Yang, Lei;
Li, Zhihong

Publication type:

Case Study

The efficacy and safety of regorafenib/fruquintinib combined with PD-1/PD-L1 for metastatic colorectal cancer: a meta-analysis based on single-arm studies.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1579293

By:

Yang, Fan;
Mao, Ying;
Huang, Hanyu;
Luo, Wen;
Liu, Li;
Chen, Wenzhi

Publication type:

Article

Early growth response 1 as a key regulator of PD-L1 expression and immune evasion in extranodal NK/T-cell lymphoma.

Published in:

Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01313-w

By:

Lee, Ji Yun;
Kim, Kui-Jin;
Park, Woochan;
Seo, Jeongmin;
Kang, Minsu;
Jung, Eun Hee;
Kim, Sang-A;
Suh, Koung Jin;
Kim, Ji-Won;
Kim, Se Hyun;
Lee, Jeong-Ok;
Kim, Jin Won;
Kim, Yu Jung;
Lee, Keun-Wook;
Kim, Jee Hyun;
Bang, Soo-Mee;
Kim, Tae Min;
Paik, Jin Ho

Publication type:

Article

Bibliometric analysis of global research on PD-L1/PD-1 pathway and neurodegenerative diseases over the last two decades (2004–2023).

Published in:

Frontiers in Aging Neuroscience, 2025, p. 1, doi. 10.3389/fnagi.2025.1570428

By:

Wu, Jialin;
Zhang, Chaojin;
Cao, Qiang;
Xuan, Wei;
Huai, Xiaorong;
Zhou, Jie;
Tian, Jie

Publication type:

Article

Author Correction: Tyrosinase in melanoma inhibits anti-tumor activity of PD-1 deficient T cells.

Published in:

2025

By:

Huang, Rong;
Wang, Yingbin;
Teng, Haitao;
Xu, Mengjun;
He, Kexin;
Shen, Yingzhuo;
Guo, Guo;
Feng, Xinyu;
Li, Tianhan;
Zhou, Binhui;
Bajenoff, Marc;
Lawrence, Toby;
Liang, Yinming;
Lu, Liaoxun;
Zhang, Lichen

Publication type:

Correction Notice

Stereotactic body radiation therapy (SBRT) increases anti-PD-1 antitumor activity by enhancing the tumor immune microenvironment in mice with metastatic hepatocellular carcinoma.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02914-4

By:

Xu, Ke;
Gu, Tao;
Su, Ke;
Liu, Xin;
He, Bingsheng;
He, Jie;
Chi, Hao;
Zhou, Xuancheng;
Liu, Hanlin;
Xiao, Rui;
Tang, Xue;
Ye, Qinni;
Zhou, Xue;
Liu, Yingpeng;
Xiong, Jie;
Wang, Pan;
Li, Han;
He, Kun;
Guo, Lu;
Han, Yunwei

Publication type:

Article

Engineered allogeneic stem cells orchestrate T lymphocyte–driven immunotherapy in immunosuppressive leptomeningeal brain metastasis.

Published in:

JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 6, p. 1151, doi. 10.1093/jnci/djaf006

By:

Kanaya, Nobuhiko;
Seddiq, Waleed;
Chen, Kok-Siong;
Kajiwara, Yoshinori;
Lama, Lucia Moreno;
Borges, Paulo;
Kuroda, Shinji;
Wakimoto, Hiroaki;
Shah, Khalid

Publication type:

Article

Increased risk of malignancy and osteoporosis in primary Sjögren's syndrome with thyroid diseases: potential implication from T cells.

Published in:

Rheumatology, 2025, v. 64, n. 5, p. 2828, doi. 10.1093/rheumatology/keae627

By:

Cui, Xiaomeng;
Li, Jun;
Sang, Yizhen;
Liu, Wei;
Lu, Yikang;
Li, Wei;
Ma, Li;
Liu, Xinying

Publication type:

Article

Impaired Overall Survival of Melanoma Patients Due to Antibiotic Use Prior to Immune Checkpoint Inhibitor Therapy: Systematic Review and Meta-Analysis.

Published in:

Cancers, 2025, v. 17, n. 11, p. 1872, doi. 10.3390/cancers17111872

By:

Gambichler, Thilo;
Weyer-Fahlbusch, Sera S.;
Overbeck, Jan;
Abu Rached, Nessr;
Becker, Jürgen C.;
Susok, Laura

Publication type:

Article

Regulatory Mechanisms and Therapeutic Targeting of PD-L1 Trafficking and Stability in Cancer Immunotherapy.

Published in:

Cancers, 2025, v. 17, n. 11, p. 1747, doi. 10.3390/cancers17111747

By:

Mani, Muralidharan;
Park, Jeong Woo;
Martin, Thomas F. J.

Publication type:

Article

Pro-Resolving Macrophage-Induced IL-35 + but Not TGF-β1 + Regulatory B Cell Activation Requires the PD-L1/PD-1 Pathway.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 11, p. 5332, doi. 10.3390/ijms26115332

By:

Cao, Guoqin;
Memida, Takumi;
Huang, Shengyuan;
Dalir Abdolahinia, Elaheh;
Ruiz, Sunniva;
Hassantash, Sahar;
Ari, Jayant;
Shindo, Satoru;
Lin, Jiang;
Kawai, Toshihisa;
Han, Xiaozhe

Publication type:

Article

Case report: a R0 resection successfully induced by T-DXd plus PD-1 inhibitor regimen in a primary unresectable stage IIIB NSCLC with ERBB2-mutation.

Published in:

2025

By:

Zhang, Ruijie;
Cheng, Sida;
Sun, Kunkun;
Zhang, Lihong;
Yan, Xiang;
Yang, Fan

Publication type:

Case Study

PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone as the first line treatment for advanced biliary tract cancer: a pooled analysis of KEYNOTE-966 and TOPAZ-1 trails.

Published in:

World Journal of Surgical Oncology, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12957-025-03877-0

By:

Wang, Jiashou;
Xu, Yun;
Hong, Bo;
Hou, Qingjian;
Chen, Wenying;
Zhang, Wenxiong;
Zheng, Wen

Publication type:

Article

The real-world safety of Nivolumab: a pharmacovigilance analysis based on the FDA adverse event reporting system.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1605958

By:

Wu, Yutong;
Zhou, Yue;
Xia, Shiyue;
Meng, Zhaoyou

Publication type:

Article

Real-World Efficacy and Safety of Anti-PD-1 Antibody Plus Apatinib and Temozolomide for Advanced Acral Melanoma.

Published in:

Cancer Management & Research, 2025, v. 17, p. 905, doi. 10.2147/CMAR.S520937

By:

Zhang, Jiaran;
Tian, Huichun;
Mao, Lili;
Li, Caili;
Wei, Xiaoting;
Gu, Junjie;
Wang, Xuan;
Zhou, Li;
Lian, Bin;
Tang, Bixia;
Yan, Xieqiao;
Li, Siming;
Cui, Chuanliang;
Chi, Zhihong;
Sheng, Xinan;
Guo, Jun;
Si, Lu

Publication type:

Article

Stevens–Johnson syndrome induced by Sintilimab: a case report and literature review.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1568316

By:

Kuang, Huan;
Huang, DongBei;
Hu, ChuXiang;
Gong, LiPing;
Yu, ZiYu;
Zhu, XunJin;
Lan, HongRong;
Huang, Gang

Publication type:

Article

Tumor‐Associated Macrophages Write the Script of Cancer Obesity Paradox.

Published in:

BioEssays, 2025, v. 47, n. 4, p. 1, doi. 10.1002/bies.202400264

By:

Sharma, Anshul;
Mishra, Alok K.

Publication type:

Article

Immune-mediated enterocolitis is associated with immune checkpoint inhibitors: A pharmacovigilance study from the FDA Adverse Event Reporting System (FAERS) database.

Published in:

PLoS ONE, 2025, v. 20, n. 6, p. 1, doi. 10.1371/journal.pone.0325760

By:

Frey, Connor

Publication type:

Article

PD-1/PD-L1 inhibitors plus bevacizumab plus chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy for advanced non-small cell lung cancer: a phase 3 RCT based meta-analysis.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1496611

By:

Song, Chao;
Qiu, Yuan;
Fan, Huan;
Han, Yongqing

Publication type:

Article

CCL2 blockade combined with PD-1/P-selectin immunomodulators impedes breast cancer brain metastasis.

Published in:

Brain: A Journal of Neurology, 2025, v. 148, n. 5, p. 1740, doi. 10.1093/brain/awae347

By:

Dangoor, Sahar Israeli;
Khoury, Rami;
Salomon, Koren;
Pozzi, Sabina;
Shahar, Shir;
Miari, Adan;
Leichtmann-Bardoogo, Yael;
Bar-Hai, Neta;
Frommer, Neta;
Yeini, Eilam;
Winkler, Tom;
Lahat, Nora Balint;
Kamer, Iris;
Hadad, Ori;
Laue, Kathrin;
Brem, Henry;
Hyde, Thomas M;
Bar, Jair;
Barshack, Iris;
Ben-David, Uri

Publication type:

Article

On the Horizon: A Global Multidisciplinary Perspective on Delivering Emerging Therapies for Patients with BCG-Naïve High-Risk NMIBC.

Published in:

Oncology & Therapy, 2025, v. 13, n. 2, p. 275, doi. 10.1007/s40487-025-00334-6

By:

Szabados, Bernadett E.;
Guerrero-Ramos, Félix;
Grande, Enrique;
Grivas, Petros;
Grünwald, Viktor;
Miguel, Marta Carpintero;
Hussain, Syed A.;
Kulkarni, Girish S.;
Wilson, Ana Lisa;
Shore, Neal D.;
Sridhar, Srikala S.;
Hoyt, Mary;
Strumeier, Samantha;
Sutton, Jennifer;
Brinkmann, Julia;
Teresi, Rosemary E.;
Todenhöfer, Tilman

Publication type:

Article

Tumor-Associated Macrophages: Polarization, Immunoregulation, and Immunotherapy.

Published in:

Cells (2073-4409), 2025, v. 14, n. 10, p. 741, doi. 10.3390/cells14100741

By:

Saeed, Abdullah Farhan

Publication type:

Article

Rethinking HIV treatment: How non‐integrase strand regimens may hold the key to better immune health.

Published in:

HIV Medicine, 2025, v. 26, n. 6, p. 879, doi. 10.1111/hiv.70020

By:

Aksak‐Wąs, Bogusz;
Skonieczna‐Żydecka, Karolina;
Parczewski, Miłosz;
Hrynkiewicz, Rafał;
Lewandowski, Filip;
Serwin, Karol;
Mielczak, Kaja;
Lenkiewicz, Franciszek;
Niedźwiedzka‐Rystwej, Paulina

Publication type:

Article

Efficacy and safety of neoadjuvant PD-1 inhibitors or PD-L1 inhibitors combined with chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis.

Published in:

Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1570467

By:

Yu, Jiaojiao;
Wang, Zhijing;
Li, Mingxu;
Zhu, Hua;
Tang, Xiaoxia;
Luan, Ke;
Zhi, Yinhuan;
Yin, Shan;
Su, Yuanqi;
Long, Jingyan;
He, Qubo;
Quan, Jieru;
Li, Chenchen

Publication type:

Article

Corrigendum: Efficacy and safety of PD-1/PD-L1 inhibitors as first-line treatment for esophageal squamous cell carcinoma: a systematic review and meta-analysis.

Published in:

2025

By:

Ren, Wei;
Zhang, Hanyu;
Li, Yixin;
Sun, Wu;
Peng, Hexiang;
Guo, Huangda;
Hou, Tianjiao;
Wang, Mengying;
Hu, Zhendong;
Wu, Tao;
Liu, Baorui

Publication type:

Correction Notice

Efficacy and safety of PD-1/PD-L1 inhibitors as first-line treatment for esophageal squamous cell carcinoma: a systematic review and meta-analysis.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1563300

By:

Ren, Wei;
Zhang, Hanyu;
Li, Yixin;
Sun, Wu;
Peng, Hexiang;
Guo, Huangda;
Hou, Tianjiao;
Wang, Mengying;
Hu, Zhendong;
Wu, Tao;
Liu, Baorui

Publication type:

Article

Unraveling the immune evasion mechanisms in the tumor microenvironment of head and neck squamous cell carcinoma.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1597202

By:

Zhao, Xuri;
Zhu, Yaping;
He, Youya;
Gu, Weiyan;
Zhou, Qi;
Jin, Bei;
Chen, Shenguo;
Lin, Haisheng

Publication type:

Article

Current and Emerging Insights into the Causes, Immunopathogenesis, and Treatment of Cutaneous Squamous Cell Carcinoma.

Published in:

Cancers, 2025, v. 17, n. 10, p. 1702, doi. 10.3390/cancers17101702

By:

Anderson, Ronald;
Mkhize, Nomzamo M.;
Kgokolo, Mahlatse M. C.;
Steel, Helen C.;
Rossouw, Theresa M.;
Anderson, Lindsay;
Rapoport, Bernardo L.

Publication type:

Article

Neoadjuvant chemotherapy with or without PD-1/PD-L1 inhibitors in resectable esophageal squamous cell carcinoma: a meta-analysis based on randomized controlled trials.

Published in:

BMC Gastroenterology, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12876-025-04030-7

By:

Zhang, Ye;
Chen, Jie;
Yu, Fenglian;
Zhang, Wenxiong;
Zhong, Yingmei

Publication type:

Article

Dynamic activation of apoptosis: conformational ensembles of cIAP1 are linked to a spring-loaded mechanism.

Published in:

Nature Structural & Molecular Biology, 2014, v. 21, n. 12, p. 1022, doi. 10.1038/nsmb.2925

By:

Gill, Michelle L;
Byrd, R Andrew

Publication type:

Article

Prognostic Factor in Elderly Patients with Advanced Non-small Cell Lung Cancer Accepting Single Agent Immunotherapy.

Published in:

2024

By:

Yao, Yuanshan;
Gao, Wen

Publication type:

Letter

ESVONC abstracts.

Published in:: Veterinary & Comparative Oncology, 2024, v. 22, p. 3, doi. 10.1111/vco.13009
Publication type:: Article

Inhibitory checkpoint molecule mRNA expression in canine soft tissue sarcoma.

Published in:

Veterinary & Comparative Oncology, 2023, v. 21, n. 4, p. 709, doi. 10.1111/vco.12934

By:

Stevenson, Valentina Beatriz;
Gudenschwager‐Basso, Erwin Kristobal;
Klahn, Shawna;
LeRoith, Tanya;
Huckle, William R.

Publication type:

Article

Regulation of programmed death ligand 1 expression by interferon‐γ and tumour necrosis factor‐α in canine tumour cell lines.

Published in:

Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 279, doi. 10.1111/vco.12886

By:

Owaki, Ryo;
Deguchi, Tatsuya;
Konnai, Satoru;
Maekawa, Naoya;
Okagawa, Tomohiro;
Hosoya, Kenji;
Kim, Sangho;
Sunaga, Takafumi;
Okumura, Masahiro

Publication type:

Article

Tumour necrosis factor stimulated gene 6 intrinsically regulates PD‐L1 expressions in breast cancer cells, leading to modulation of tumour microenvironment.

Published in:

Veterinary & Comparative Oncology, 2023, v. 21, n. 2, p. 255, doi. 10.1111/vco.12884

By:

Lee, Jeong‐Hwa;
An, Ju‐Hyun;
Youn, Hwa‐Young

Publication type:

Article

Long‐term survival of dogs with stage 4 oral malignant melanoma treated with anti‐canine PD‐1 therapeutic antibody: A follow‐up case report.

Published in:

Veterinary & Comparative Oncology, 2022, v. 20, n. 4, p. 901, doi. 10.1111/vco.12829

By:

Igase, Masaya;
Inanaga, Sakuya;
Tani, Kenji;
Nakaichi, Munekazu;
Sakai, Yusuke;
Sakurai, Masashi;
Kato, Masahiro;
Tsukui, Toshihiro;
Mizuno, Takuya

Publication type:

Article

Evaluation of lymphocyte‐specific programmed cell death protein 1 receptor expression and cytokines in blood and urine in canine urothelial carcinoma patients.

Published in:

Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 427, doi. 10.1111/vco.12788

By:

Pinard, Christopher J.;
Stegelmeier, Ashley A.;
Bridle, Byram W.;
Mutsaers, Anthony J.;
Wood, R. Darren;
Wood, Geoffrey A.;
Woods, J. Paul;
Hocker, Samuel E.

Publication type:

Article

Characterizing the molecular and immune landscape of canine bladder cancer.

Published in:

Veterinary & Comparative Oncology, 2022, v. 20, n. 1, p. 69, doi. 10.1111/vco.12740

By:

Cronise, Kathryn E.;
Das, Sunetra;
Hernandez, Belen G.;
Regan, Daniel P.;
Dailey, Deanna D.;
McGeachan, Robert I.;
Lana, Susan E.;
Page, Rodney L.;
Gustafson, Daniel L.;
Duval, Dawn L.

Publication type:

Article

Abstracts‐Posters.

Published in:: Veterinary & Comparative Oncology, 2021, v. 19, p. 4, doi. 10.1111/vco.12764
Publication type:: Article